Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2022-02-23 Director's Dealing
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Lee Tae Hee) of Antrogen Co., Ltd. This type of filing is a standard regulatory requirement for insiders to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category.
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (Korea). This is a standard regulatory filing used to disclose insider transactions or changes in share ownership by company executives. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Choi Yun Jung) of Antrogen Co., Ltd. This type of filing, which details personal share transactions by company insiders, is classified as a Director's Dealing (DIRS) report.
2022-02-22 Korean
불성실공시법인지정(공시불이행)
Regulatory Filings Classification · 100% confidence The document is a formal notice regarding the designation of the company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a failure to comply with disclosure obligations. It details the penalty points, fines, and regulatory basis for this action. Since this is a regulatory announcement regarding compliance and legal/regulatory status rather than a financial report or specific corporate action like M&A or dividends, it falls under the general regulatory filing category.
2022-02-17 Korean
주권매매거래정지(불성실공시법인 지정)
Delisting Announcement Classification · 100% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to being designated as an unfaithful disclosure corporation. It cites specific regulatory rules (KOSDAQ market disclosure regulations) and provides the duration of the suspension. Since it is a regulatory announcement regarding market status rather than a financial report or a specific corporate action like a dividend or M&A, it falls under the general regulatory filings category.
2022-02-17 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Antrogen. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors/auditors, and amendments to the articles of incorporation. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on meeting agenda items.
2022-02-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.